To correlate serum proteomics patterns with PET/CT findings to improve cancer diagnosis,
staging, prognosis, and therapy monitoring.
Inclusion Criteria:1. Patients must have a PET/CT study performed at the time of blood
2. Patients must understand and voluntarily sign an Informed Consent form after the
contents have been fully explained to them.
Exclusion Criteria:1. Patients who are not eligible for a PET/CT study.